Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis

Citation
E. Mena et C. Rohowsky-kochan, Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis, ACT NEUR SC, 100(2), 1999, pp. 92-96
Citations number
26
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ACTA NEUROLOGICA SCANDINAVICA
ISSN journal
00016314 → ACNP
Volume
100
Issue
2
Year of publication
1999
Pages
92 - 96
Database
ISI
SICI code
0001-6314(199908)100:2<92:EOCMOP>2.0.ZU;2-B
Abstract
Objective - To determine whether there was aberrant expression of costimula tory molecules and their receptors on peripheral blood mononuclear cells of MS patients and healthy individuals and whether expression correlated with disease status. Methods - Forty-six patients with MS and 29 healthy indivi duals were analyzed by direct 2-color immunofluorescence flow cytometry for expression of CD80, CD86, CD28 and CTLA-4 on T and B cells and monocytes. Results - Expression of CD80 on CD4(+) T cells was upregulated in progressi ng MS patients compared to stable MS patients and controls. Marked increase in the expression of CD80 and CD86 was seen on both CD4(+) and CD8(+) T ce lls from an MS patient with rapidly progressing disease. No difference in t he expression of the costimulatory molecules or their ligands was seen betw een IFN-P treated and non-treated MS patients. Conclusions - Aberrant expre ssion of costimulatory molecules occurs on T lymphocytes in MS patients wit h progressing disease.